AnnouncementJanuary 13
Company Operations During COVID-19 Imposed State of Emergency in Seven Prefectures
Our sincere condolences to victims of COVID-19, and hopes for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals who are working at the forefront to treat patients, and everyone who is helping to support the community infrastructure.
Responding to the COVID-19-related state of emergency in the seven prefectures including Osaka and Aichi declared by the Japanese Government on January 13, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be closing company sites from January 14, prioritizing the safety of customers and employees. During the closure, PHC Group employees at the sites listed below will continue business operations by working from home, except in special cases where they perform essential duties that cannot be performed remotely, and will respond to customer inquiries by e-mail, phone calls, etc.
· Site closures
PHC Corporation |
Osaka Site (Address: OAP Tower 16F, 1-8-30 Tenmabashi, Kita-ku, Osaka City, Osaka)
[Biomedical Business Unit]
Kinki Sales Office/Pharmacy System Sales Office/Delicart Sales Office
[Medical Information Systems Business Unit]
West Japan Sales Office
Chubu Sales Office (Address: Nagoya Panasonic Building 6F, 1-23-30 Izumi, Higashi-ku, Nagoya City, Aichi)
[Biomedical Business Unit]
Chubu Sales Office/Pharmacy System Sales Office/Delicart Sales Office
Kyushu Sales Office (Address: Riverain Center Building 11F, 3-1 Shimokawabata-machi, Hakata-ku, Fukuoka City, Fukuoka)
[Biomedical Business Unit]
Kyushu Sales Office/Pharmacy System Sales Office
[Medical Information Systems Business Unit]
Kyushu Sales Office |
PHC Associates Corporation |
Gifu Office (Address: Lapis Tower 8F, 1-2-3 Yabutaminami, Gifu City, Gifu) |
Details of additional upcoming measures will be announced respectively by each business unit in charge, where appropriate. Resuming of operations at these sites will be considered depending on government policies and the status of the COVID-19. We appreciate your understanding and apologize for any inconvenience or disruption that you may experience.
The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of infection, while working to ensure stable supply for customers and patients who rely on our products and services.